ALDH1A1 and cancer: In cancer, RA binds to RARα and alternative transcriptional partners are recruited into the nucleus and enhance cell proliferation, drug resistance, and inhibition of apoptosis by activating c-MYC, cyclin D1, and ALDH1A1 [20,21].